EUVIMEDEUVIMED entdecken
Crossref

Biomanufacturing of Therapeutically Relevant Chondroitin Sulfate C via Engineered Microbes

Aditi Dey Tithi, Hana Zeghal, Yuefan Song iD, Elena E Paskaleva, Sweta Vangaveti, Mattheos Koffas iD

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.5c00780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Aditi Dey Tithi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180, United States. Hauptthemen laut MEDLINE: Chondroitin Sulfates, Escherichia coli, Sulfotransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Rensselaer Polytechnic Institute, Alcon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chondroitin sulfate C (CS-C) is a biologically significant glycosaminoglycan in which a precise 6-O-sulfation pattern confers critical structural and signaling functions in connective and neural tissues. Here, we report the first functional expression of human chondroitin 6-O-sulfotransferase-1 (C6ST-1) in Escherichia coli, enabling cell-free biosynthesis of CS-C. By applying structure-guided protein engineering combining transmembrane truncation, His6 -MBP fusion, and PROSS-directed stabilizing mutations, we generated a soluble and catalytically active variant in E. coli Origami B (DE3) and modified Shuffle T7 Express. Under optimized reaction conditions (MES buffer pH 5.5, 30 °C, Mg2+/Ca2+/Mn2+ with protamine sulfate), the engineered enzyme catalyzed up to 67% sulfation of chondroitin (CS-O) to CS-C, verified via SAX-HPLC. Kinetic and molecular dynamics analyses revealed enhanced substrate affinity and catalytic efficiency for the M9 Δ131 mutant. This study establishes a sustainable, animal-free platform for high-purity CS-C biomanufacturing and provides a generalizable strategy for engineering eukaryotic sulfotransferases for functional expression in bacterial hosts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chondroitin SulfatesEscherichia coliSulfotransferasesProtein EngineeringHumansCarbohydrate SulfotransferasesKinetics

Stichwörter der Autor:innen

chondroitin sulfateglycosaminoglycanprotein engineeringsulfotransferase

Substanzen

Chondroitin SulfatesSulfotransferasesCarbohydrate Sulfotransferases

Autor:innen und Institutionen

  • Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
  • Department of Chemical and Biological Engineering, Troy, New York 12180, United States.
  • The RNA Institute, University at Albany, State University of New York, Albany, New York 12222, United States.

ORCID-Profile: Yuefan Song, Mattheos Koffas

Förderung

  • Rensselaer Polytechnic Institute
  • Alcon

Zitieren

APA

Tithi, A. D., Zeghal, H., Song, Y., Paskaleva, E. E., Vangaveti, S., & Koffas, M. (2026). Biomanufacturing of Therapeutically Relevant Chondroitin Sulfate C via Engineered Microbes. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00780

Vancouver

Tithi AD, Zeghal H, Song Y, Paskaleva EE, Vangaveti S, Koffas M. Biomanufacturing of Therapeutically Relevant Chondroitin Sulfate C via Engineered Microbes. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.5c00780

BibTeX
@article{Tithi2026,
  author = {Tithi, Aditi Dey and Zeghal, Hana and Song, Yuefan and Paskaleva, Elena E and Vangaveti, Sweta and Koffas, Mattheos},
  title = {Biomanufacturing of Therapeutically Relevant Chondroitin Sulfate C via Engineered Microbes},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.5c00780}
}
Kostenlos starten →